Table 4.
Comparison of the groups with and without transarterial chemoembolization treatment at different times from the liver transplantation
TACE |
No TACE | χ2 | P value | |||
≤ 1 mo | 1-3 mo | ≥ 3 mo | ||||
Milan criteria | 2 | 1 | 8 | 5 | 16 | 0.001a |
UCSF criteria | 1 | 1 | 7 | 6 | 15 | 0.002a |
BUCSF criteria | 8 | 9 | 5 | 9 | 31 | < 0.001a |
P < 0.05, TACE vs no TACE. TACE: Transarterial chemoembolization.